Jelly Roll said no to Ozempic but yes to TRT and cut over 300 pounds

Country music star Jelly Roll has accomplished what many thought impossible: losing over 300 pounds without taking the trendy weight loss d**g Ozempic. In a conversation on The Joe Rogan Experience, the 41-year-old artist opened up about his remarkable transformation, revealing the unconventional path he took to save his life.

When Jelly Roll approached his 39th birthday weighing over 500 pounds, he realized he had a choice to make. “I don’t think I’ve ever met a 500 lb 40-year-old,” he admitted. “They don’t stick around very often. Usually, that’s when they stop off.” The wake-up call prompted him to take action, but not in the way many celebrities have chosen.

While GLP-1 stuff like Ozempic has become the go-to solution for rapid weight loss in Hollywood, Jelly Roll deliberately avoided them. His wife’s manager tried the shot and experienced severe stomach issues, which scared him off.

“I have bad reflux,” he explained. “That’s the worst thing a singer can have. Nothing is worse for us than reflux.” Instead of taking the pharmaceutical route, Jelly Roll committed to a slower, more sustainable approach.

Working with Dr. Denise at Ways to Well, Jelly Roll discovered his insulin levels were dangerously high—over 40 when they should have been under five.

Rather than jumping straight to GLP-1s, they started him on a low dose of metformin, just 500 milligrams compared to the typical 2,000 milligrams prescribed to diabetics. “We’re not trying to rush it and throw a bunch of GL1s at it,” he said. “We’re going to do this really slow.”

However, Jelly Roll wasn’t completely “natty” in his transformation. His testosterone levels were critically low—in the 50s when they should be around 750. His free testosterone was just 2.3. Today, after testosterone replacement therapy, his free testosterone is 149.

“You remember that problem we talked about with my wife?” he joked. “Not anymore. I’m walking around the house like a tiger.”

The results speak for themselves. His insulin dropped from over 40 to 4.6. His A1C went from 6.4 to 5.4. His C-reactive protein, an inflammation marker, plummeted from the sixes to 1.2. His vitamin D jumped from 28 to 100.

Perhaps most remarkably, he regained his ability to see colors properly after years of what he describes as being “colorblind” due to massive inflammation from sugar consumption.

Beyond the medical interventions, Jelly Roll’s success came from addressing the root psychological causes of his obesity. He spent weeks in therapy with Mary B, who wrote the curriculum for food addiction, learning that “80 to 90% of compulsive eating happens between the ears, not the teeth.” He discovered he wasn’t eating because he was hungry—he was eating to avoid dealing with emotions and stress.

The transformation required complete lifestyle changes. He started with simple goals: a cold plunge and 10,000 steps daily. On his first day, despite pouring rain, he refused to break his promise to himself.

“I told y’all I was going to go do this walk and I’m going to do this walk,” he remembered. His family cheered him on when he returned, a moment that crystallized his commitment to change.

Now in the 260s with approximately 35 pounds of excess skin, Jelly Roll has completely transformed his relationship with food and exercise. He runs regularly with bow hunting legend Cam Hanes and recently completed his first 10K. He’s traded processed foods for whole foods, given up sugar almost entirely, and learned to communicate his needs rather than eating his feelings.

For those struggling with obesity, Jelly Roll’s message is clear: pharmaceutical shortcuts aren’t necessary. “You will grossly overestimate what you can do in 90 days but underestimate what you can do in a year when it comes to your health,” he advised.

By addressing hormonal imbalances through TRT, slowly correcting insulin resistance, doing the mental work in therapy, and committing to sustainable lifestyle changes, he proved that lasting transformation is possible—even without Ozempic.